Sol-Gel Technologies Ltd (SLGL)

$7.52 +0.62 (8.99%)
Market Cap 20.95M
Revenue (ttm) 11.54M
Net Income (ttm) -10.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -91.68%
Debt to Equity Ratio 0.00
Volume 104,800
Avg Vol 41,051
Day's Range N/A - N/A
Shares Out 2.79M
Stochastic %K 51%
Beta 1.10
Analysts Strong Sell
Price Target $60.00

Company Profile

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatm...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 8 931 3433
Address:
7 Golda Meir Street, Weizmann Science Park, Ness Ziona, Israel
PennyStocksMom
PennyStocksMom Jun. 13 at 1:14 PM
🌅 watchlist part 2 ✅️ $TPET mid 1.50 support, if above 1.75, have potential to 2/2.20 ✅️ $CGBS .15 support, if above .20, have potential to .30/.35 ✅️ $SLGL low 7 support, if above 7.50, have potential to 8/8.40, ultra small float <1m, ✅️ $SDOT 1.30 support, if above 1.75, have potential to 2/2.30, small float ✅️ CGTL low 2 support, if above 2.40, have potential to 2.65/.70, small float, ✅️ $ALZN low 3.0 support, if above 3.50, have potential to 4.0/.50/.75, ultra small float <1m, ✅️ ZDGE low 3 support, if above 3.40, have potential to 3.70/.90, 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if below current support 🚫🚫 Avoid chasing long into strength near resistance. 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
0 · Reply
PaulLaurent
PaulLaurent Jun. 13 at 5:43 AM
4:00 AM EST Watchlist – Part One 🔍 $SLGL – Insider alert: a new Schedule 13D/A reveals that Moshe Arkin (and his vehicle Arkin Dermatology Ltd.) now controls ~65.31% of Sol‑Gel Tech following heavy buys in May, including a 91k+‑share purchase on May 29. This level of insider accumulation signals a consolidation of control and strong confidence in the company. $SDOT – Sadot Group, Inc. surged in after‑hours trading as a speculative mover—watch for continued omentum. $CGTL – Creative Global Technology Holdings, Inc. showing signs of a multi‑day runner; gains have been steady, trending higher on low float setup. $SGMT – Sagimet Biosciences, Inc. heating up as a potential multi‑day runner after biotech buzz—clinical pipeline news could be catalyst. $KLTO – Klotho Neurosciences, Inc. remains on watch for multi‑day momentum; chart forming potential base breakouts.
0 · Reply
topstockalerts
topstockalerts Jun. 13 at 4:04 AM
$SLGL keep an eye here
0 · Reply
PennyStocksMom
PennyStocksMom Jun. 13 at 3:39 AM
🌅 watchlist part 1 ✅️ $SLGL mid 8.50 support, if above 9, have potential to 9.50/10, ultra small float <1m, ✅️ $SDOT mid 1.50 support, if above 2, have potential to 2.30/.40, small float ✅️ $CGTL low 2 support, if above 2.40, have potential to 2.65/.70, small float, ✅️ $ALZN mid 3.50 support, if above 4, have potential to 4..40/.50/.75, ultra small float <1m, ✅️ $ZDGE low 3 support, if above 3.40, have potential to 3.70/.90, 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if below current support 🚫🚫 Avoid chasing long into strength near resistance. 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
1 · Reply
AlertsAndNews
AlertsAndNews Jun. 13 at 3:03 AM
Updated gappers in after hours trading $SDOT $SLGL $CGTL $RH $ALZN Futures getting hammered. Dow futures does 630 point as I write this. Let's finish the week strong tomorrow.
0 · Reply
toccoc
toccoc Jun. 13 at 2:22 AM
0 · Reply
LamontWhoDat
LamontWhoDat Jun. 13 at 1:49 AM
$SLGL do anyone have the overnight price
0 · Reply
toccoc
toccoc Jun. 13 at 12:54 AM
$SLGL next $RGC High insider holdings + good clinical news = 3000% up
0 · Reply
LongDuckDongFever2020
LongDuckDongFever2020 Jun. 13 at 12:34 AM
$SLGL Cash is $6+ share with no outstanding debt per latest 20-F filling April 2025. Took a look at a few of the skin diseases they're treating - Gorlin's syndrome and Darier disease. Very sad for those folks affected. Could be a big one in the making... Do your own DD. NFA
0 · Reply
DaBullRunner
DaBullRunner Jun. 12 at 11:58 PM
$ALZN $SDOT $SLGL $ZBAI 🚨LAST CALL🚨
0 · Reply
Latest News on SLGL
Sol-Gel Reports First Quarter 2025 Results

May 23, 2025, 7:15 AM EDT - 24 days ago

Sol-Gel Reports First Quarter 2025 Results

Sol-Gel Announces Reverse Share Split

May 1, 2025, 7:00 AM EDT - 6 weeks ago

Sol-Gel Announces Reverse Share Split

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

Apr 17, 2025, 8:40 AM EDT - 2 months ago

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

Global Sol-Gel Coatings Market Research 2025-2035: Competitive Landscape, Functional Properties and Applications, End-users, Technology Fundamentals, Overview and Growth Analysis

Apr 7, 2025, 10:01 AM EDT - 2 months ago

Global Sol-Gel Coatings Market Research 2025-2035: Competitive Landscape, Functional Properties and Applications, End-users, Technology Fundamentals, Overview and Growth Analysis

Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Nov 15, 2024, 7:00 AM EST - 7 months ago

Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Aug 17, 2024, 11:27 AM EDT - 10 months ago

UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Aug 16, 2024, 7:00 AM EDT - 10 months ago

Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Sol-Gel Technologies Announces Management Realignment

Jul 15, 2024, 7:00 AM EDT - 1 year ago

Sol-Gel Technologies Announces Management Realignment

Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates

May 20, 2024, 7:00 AM EDT - 1 year ago

Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel

May 16, 2024, 6:00 AM EDT - 1 year ago

Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel

Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream

Apr 1, 2024, 7:00 AM EDT - 1 year ago

Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream

Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

Mar 13, 2024, 7:00 AM EDT - 1 year ago

Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study

Nov 30, 2023, 7:00 AM EST - 1 year ago

Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study

Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610

Nov 28, 2023, 8:06 AM EST - 1 year ago

Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610

Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 9, 2023, 7:00 AM EST - 1 year ago

Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

Aug 30, 2023, 8:00 AM EDT - 1 year ago

Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Aug 10, 2023, 7:00 AM EDT - 2 years ago

Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada

Jun 6, 2023, 7:30 AM EDT - 2 years ago

Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada

Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Update

May 12, 2023, 7:00 AM EDT - 2 years ago

Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Update

Sol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference

Mar 20, 2023, 7:00 AM EDT - 2 years ago

Sol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference

Sol-Gel Reports Full-Year 2022 Financial Results and Corporate Developments

Mar 10, 2023, 7:00 AM EST - 2 years ago

Sol-Gel Reports Full-Year 2022 Financial Results and Corporate Developments

Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings

Jan 27, 2023, 7:29 AM EST - 2 years ago

Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings

Sol-Gel Acquires Patidegib, a Phase 3, FDA-Breakthrough-Designated Orphan Product Candidate to Pursue Potential Market of Over $300 Million

Jan 27, 2023, 7:00 AM EST - 2 years ago

Sol-Gel Acquires Patidegib, a Phase 3, FDA-Breakthrough-Designated Orphan Product Candidate to Pursue Potential Market of Over $300 Million

Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Nov 10, 2022, 4:00 AM EST - 2 years ago

Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Sol-Gel Technologies Appoints Michael Glezin Vice President, Business Development

Oct 3, 2022, 8:00 AM EDT - 2 years ago

Sol-Gel Technologies Appoints Michael Glezin Vice President, Business Development

Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Aug 4, 2022, 6:00 AM EDT - 3 years ago

Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update

May 13, 2022, 7:00 AM EDT - 3 years ago

Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update

Sol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY®

Apr 25, 2022, 7:00 AM EDT - 3 years ago

Sol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY®

Sol-Gel Technologies Announces the Commercial Availability of TWYNEO®

Apr 14, 2022, 8:30 AM EDT - 3 years ago

Sol-Gel Technologies Announces the Commercial Availability of TWYNEO®

Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments

Mar 30, 2022, 7:00 AM EDT - 3 years ago

Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments

Sol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA

Mar 25, 2022, 11:00 AM EDT - 3 years ago

Sol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA

Sol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference

Dec 22, 2021, 4:05 PM EST - 3 years ago

Sol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference

Sol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY®

Dec 21, 2021, 7:00 AM EST - 3 years ago

Sol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY®

Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments

Nov 11, 2021, 7:00 AM EST - 3 years ago

Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments

Sol-Gel Technologies to Present Live at Jefferies London Healthcare Conference

Nov 9, 2021, 7:05 AM EST - 3 years ago

Sol-Gel Technologies to Present Live at Jefferies London Healthcare Conference

Sol-Gel Technologies to Present at Upcoming Cantor Virtual Global Healthcare Conference

Sep 22, 2021, 7:30 AM EDT - 4 years ago

Sol-Gel Technologies to Present at Upcoming Cantor Virtual Global Healthcare Conference

Sol-Gel Technologies to Present at Upcoming H.C. Wainwright Global Investment Conference

Sep 9, 2021, 8:30 AM EDT - 4 years ago

Sol-Gel Technologies to Present at Upcoming H.C. Wainwright Global Investment Conference

Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Developments

Aug 4, 2021, 7:05 AM EDT - 4 years ago

Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Developments

Sol-Gel Wins FDA Approval For Fixed-Dose Combination Of Tretinoin, Benzoyl Peroxide For Acne Vulgaris

Jul 27, 2021, 10:26 AM EDT - 4 years ago

Sol-Gel Wins FDA Approval For Fixed-Dose Combination Of Tretinoin, Benzoyl Peroxide For Acne Vulgaris

Sol-Gel Technologies Announces FDA Approval of TWYNEO®

Jul 27, 2021, 9:15 AM EDT - 4 years ago

Sol-Gel Technologies Announces FDA Approval of TWYNEO®

Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021

Jul 20, 2021, 7:05 AM EDT - 4 years ago

Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021

Sol-Gel Announces Pipeline Update and Future Development Plans

Jun 28, 2021, 5:10 AM EDT - 4 years ago

Sol-Gel Announces Pipeline Update and Future Development Plans

Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States

Jun 28, 2021, 5:00 AM EDT - 4 years ago

Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States

Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update

May 13, 2021, 7:05 AM EDT - 4 years ago

Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update

Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today

Apr 27, 2021, 12:03 PM EDT - 4 years ago

Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today

BNGO ALDX CYCN

Sol-Gel Technologies Provides Update on FDA Review of EPSOLAY®

Apr 27, 2021, 10:02 AM EDT - 4 years ago

Sol-Gel Technologies Provides Update on FDA Review of EPSOLAY®

Sol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update

Mar 4, 2021, 7:05 AM EST - 4 years ago

Sol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update

Sol-Gel Technologies to Present at Upcoming 2021 Raymond James Institutional Investors Conference and H.C. Wainwright Global Life Sciences Conference

Feb 24, 2021, 7:05 AM EST - 4 years ago

Sol-Gel Technologies to Present at Upcoming 2021 Raymond James Institutional Investors Conference and H.C. Wainwright Global Life Sciences Conference

Sol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect Conference

Jan 11, 2021, 7:05 AM EST - 4 years ago

Sol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect Conference

PennyStocksMom
PennyStocksMom Jun. 13 at 1:14 PM
🌅 watchlist part 2 ✅️ $TPET mid 1.50 support, if above 1.75, have potential to 2/2.20 ✅️ $CGBS .15 support, if above .20, have potential to .30/.35 ✅️ $SLGL low 7 support, if above 7.50, have potential to 8/8.40, ultra small float <1m, ✅️ $SDOT 1.30 support, if above 1.75, have potential to 2/2.30, small float ✅️ CGTL low 2 support, if above 2.40, have potential to 2.65/.70, small float, ✅️ $ALZN low 3.0 support, if above 3.50, have potential to 4.0/.50/.75, ultra small float <1m, ✅️ ZDGE low 3 support, if above 3.40, have potential to 3.70/.90, 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if below current support 🚫🚫 Avoid chasing long into strength near resistance. 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
0 · Reply
PaulLaurent
PaulLaurent Jun. 13 at 5:43 AM
4:00 AM EST Watchlist – Part One 🔍 $SLGL – Insider alert: a new Schedule 13D/A reveals that Moshe Arkin (and his vehicle Arkin Dermatology Ltd.) now controls ~65.31% of Sol‑Gel Tech following heavy buys in May, including a 91k+‑share purchase on May 29. This level of insider accumulation signals a consolidation of control and strong confidence in the company. $SDOT – Sadot Group, Inc. surged in after‑hours trading as a speculative mover—watch for continued omentum. $CGTL – Creative Global Technology Holdings, Inc. showing signs of a multi‑day runner; gains have been steady, trending higher on low float setup. $SGMT – Sagimet Biosciences, Inc. heating up as a potential multi‑day runner after biotech buzz—clinical pipeline news could be catalyst. $KLTO – Klotho Neurosciences, Inc. remains on watch for multi‑day momentum; chart forming potential base breakouts.
0 · Reply
topstockalerts
topstockalerts Jun. 13 at 4:04 AM
$SLGL keep an eye here
0 · Reply
PennyStocksMom
PennyStocksMom Jun. 13 at 3:39 AM
🌅 watchlist part 1 ✅️ $SLGL mid 8.50 support, if above 9, have potential to 9.50/10, ultra small float <1m, ✅️ $SDOT mid 1.50 support, if above 2, have potential to 2.30/.40, small float ✅️ $CGTL low 2 support, if above 2.40, have potential to 2.65/.70, small float, ✅️ $ALZN mid 3.50 support, if above 4, have potential to 4..40/.50/.75, ultra small float <1m, ✅️ $ZDGE low 3 support, if above 3.40, have potential to 3.70/.90, 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if below current support 🚫🚫 Avoid chasing long into strength near resistance. 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
1 · Reply
AlertsAndNews
AlertsAndNews Jun. 13 at 3:03 AM
Updated gappers in after hours trading $SDOT $SLGL $CGTL $RH $ALZN Futures getting hammered. Dow futures does 630 point as I write this. Let's finish the week strong tomorrow.
0 · Reply
toccoc
toccoc Jun. 13 at 2:22 AM
0 · Reply
LamontWhoDat
LamontWhoDat Jun. 13 at 1:49 AM
$SLGL do anyone have the overnight price
0 · Reply
toccoc
toccoc Jun. 13 at 12:54 AM
$SLGL next $RGC High insider holdings + good clinical news = 3000% up
0 · Reply
LongDuckDongFever2020
LongDuckDongFever2020 Jun. 13 at 12:34 AM
$SLGL Cash is $6+ share with no outstanding debt per latest 20-F filling April 2025. Took a look at a few of the skin diseases they're treating - Gorlin's syndrome and Darier disease. Very sad for those folks affected. Could be a big one in the making... Do your own DD. NFA
0 · Reply
DaBullRunner
DaBullRunner Jun. 12 at 11:58 PM
$ALZN $SDOT $SLGL $ZBAI 🚨LAST CALL🚨
0 · Reply
DaBullRunner
DaBullRunner Jun. 12 at 11:49 PM
$SDOT 🚨LAST CALL🚨 BEFORE WE WAKE UP TO $2+ EASY ALSO $ZBAI is going to $1+ in due time 🤫 $SLGL $ALZN $CTGL
1 · Reply
DaBullRunner
DaBullRunner Jun. 12 at 11:43 PM
$CGTL absolutely NAILED this call PERFECTLY👇🏆 READ THE TIMES BELOW🚨 I’m telling you $ZBAI is going to $1+ in due time Just look at what’s happening with my $SDOT right now $SLGL $ALZN what a day
0 · Reply
DaBullRunner
DaBullRunner Jun. 12 at 11:17 PM
$SDOT is paying me BIG time Just wait until social media starts talking about this ticker Also, smart money is quietly accumulating $ZBAI 🚨 Smart money is always at least 5 steps ahead of the market $SLGL $ALZN $CGTL what a day
1 · Reply
AlertsAndNews
AlertsAndNews Jun. 12 at 11:06 PM
Gappers here in after hours trading $SLGL $ALZN $SDOT $RH $CGTL I'll try and update later this evening.
0 · Reply
casedoog
casedoog Jun. 12 at 10:00 PM
$SLGL what is up with Schwab not letting us buy all these runners. $KNW was one last week and now this. Anyone have an answer??
2 · Reply
tariq7863a
tariq7863a Jun. 12 at 9:12 PM
$SLGL soon 7.0 bogus up
0 · Reply
Rasto2020
Rasto2020 Jun. 12 at 9:08 PM
$SLGL from $7.10-$11.50 62% wow
0 · Reply
inLOWoutBIG
inLOWoutBIG Jun. 12 at 9:07 PM
so how does a garbage company like $SLGL get a 100% run in AH on shit earnings, but a company like $GTEC cant break $3 on actual good earnings?
0 · Reply
tariq7863a
tariq7863a Jun. 12 at 9:05 PM
$SLGL all fraud. soon 7.0
0 · Reply
Rasto2020
Rasto2020 Jun. 12 at 9:03 PM
$SLGL bam, it did almost 100%
0 · Reply
doodledo77
doodledo77 Jun. 12 at 8:56 PM
$SLGL team watching 👀👀👀👀👀👀👀👀
0 · Reply
tariq7863a
tariq7863a Jun. 12 at 8:53 PM
$SLGL be ready. dumping started
0 · Reply